SLAMF1 and B-cell chronic lymphocytic leukemia: Pathological CLL B cells from patients with CLL showed significantly decreased expression of SLAMF1/CD150 in comparison with normal B cells from healthy control subjects or normal polyclonal B cells present in CLL patient samples [36].